Assessment of kallikrein 6 as a cross-sectional and longitudinal biomarker for Alzheimer’s disease

Assessment of kallikrein 6 as a cross-sectional and longitudinal biomarker for Alzheimer’s disease

Abstract Background Kallikrein 6 (KLK6) is known to be an age-related protease expressed at high levels in the central nervous system. It was previously shown to be involved in proteolysis of extracellular proteins implicated in neurodegenerative diseases such as Alzheimer’s disease (AD), prompting...

Full description

Bibliographic Details
Main Authors: Kalicharan Patra, Antoninus Soosaipillai, Sigrid Botne Sando, Camilla Lauridsen, Guro Berge, Ina Møller, Gøril Rolfseng Grøntvedt, Geir Bråthen, Ilijana Begcevic, Simon Moussaud, Lennart Minthon, Oskar Hansson, Eleftherios P. Diamandis, Linda R. White, Henrietta M. Nielsen
Format: Article
Language:English
Published: BMC 2018-01-01
Series:Alzheimer’s Research & Therapy
Subjects:
KLK6
Neurosin
Biomarker
Neurodegeneration
Alzheimer’s disease
Online Access:http://link.springer.com/article/10.1186/s13195-018-0336-4

Internet

http://link.springer.com/article/10.1186/s13195-018-0336-4

Similar Items